337. Homocystinuria Clinical trials / Disease details
Clinical trials : 13 / Drugs : 13 - (DrugBank : 4) / Drug target genes : 2 - Drug target pathways : 23
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT04015557 (ClinicalTrials.gov) | February 11, 2022 | 28/5/2019 | Effect of Acetaminophen and N-Acetylcysteine on Liver Metabolism on Homocystinuria | Functional Consequences and Therapeutic Intervention in Hampered Production of Cysteine, Glutathione and Taurine in Classical Homocystinuria | CBS Deficiency | Drug: Acetaminophen;Drug: N-acetylcysteine | Hospital de Clinicas de Porto Alegre | Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil | Suspended | 18 Years | 65 Years | All | 10 | Phase 1/Phase 2 | Brazil |
2 | NCT00483314 (ClinicalTrials.gov) | November 2007 | 5/6/2007 | Homocystinuria: Treatment With N-Acetylcysteine | Homocystinuria: Treatment With N-Acetylcysteine | Homocystinuria | Drug: N-acetylcysteine | McGill University Health Center | March of Dimes | Completed | 18 Years | N/A | Both | 5 | Phase 2 | Canada |